“…As reported previously, recurrent mutations of MEN1 and VHL are identified in distinct NET hereditary syndromes, and those involving DAXX, ATRX (found in a mutually-exclusive manner in pNETs) [30], and mTOR pathway genes (PTEN, TSC2, NF1, PIK3CA) are commonly found in sporadic PNETs [21,31,32]. In turn, in most sporadic and familial PDACs, four key driver mutations in KRAS, TP53, SMAD4, and CDKN2A, and mutations in other oncogenes (c-myc, PAK4, HER2), tumor suppressor genes (PTEN, BRCA2, PALB2, and PRSS1), and DNA mismatch repair genes (MLH1, MSH2, MSH6, and PMS2) have been found [9].…”